SCHEMBL10748745

SCHEMBL10748745

S=c1c2ccccc2[se]n1-c1c(Cl)ncnc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ METAP2 P50579 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ QSOX1 O00391 1/20 0.36
▸ RGS12 O14924 1/20 0.36
▸ PMM2 O15305 1/20 0.36
▸ PLIN1 O60240 1/20 0.36
▸ GMNN O75496 1/20 0.36
▸ BBOX1 O75936 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYBB P04839 1/20 0.36
▸ BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916963 0.81 METAP2 (0.54) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10501640 0.76 METAP2 (0.37) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10501870 0.74 METAP2 (0.39) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10747582 0.73 METAP2 (0.40) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10747007 0.73 METAP2 (0.38) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10501733 0.73 METAP2 (0.36) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10501392 0.73 METAP2 (0.34) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10503039 0.73 METAP2 (0.41) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10501737 0.72 METAP2 (0.41) ALDH1A1MAPTHTTMETAP2KDM4E
SCHEMBL10502616 0.72 METAP2 (0.46) ALDH1A1MAPTHTTMETAP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
Send feedback